{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0224","parameter":[{"name":"assessentDate","valueDate":"2007-02-20"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0224","name":[{"text":"Dose 1 to dose 3 interval of Comvax is 16 weeks.   Series complete for Hep B. \nEvaluation_Test_Type: Interval: At Minimum\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete."}],"gender":"female","birthDate":"2006-08-08"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2006-10-31T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2006-12-22T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0224-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"51","display":"COMVAX"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"COMVAX"}]},"patient":{"reference":"Patient/2013-0224"},"date":"2007-02-20T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0224"},"recommendation":[{"date":"2007-02-20T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: Interval: At Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks from dose #1 that the dose is considered to be valid.  The series is complete.","series":"HepB"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}